General Information


DRACP ID  DRACP06052

Peptide Name  

Sequence  CIELLQAR

Sequence Length  8

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C40H72N12O12S

Absent amino acids  DFGHKMNPSTVWY

Common amino acids  L

Mass  107020

Pl  6.23

Basic residues  1

Acidic residues  1

Hydrophobic residues  4

Net charge  0

Boman Index  -942

Hydrophobicity  61.25

Aliphatic Index  158.75

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN113171342A

Patent Title  Tumor targeting nano-micelle based on hyaluronic acid as well as preparation and application of tumor targeting nano-micelle

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.